Cortex Discovery is a pharmaceutical company focused on AI-driven drug discovery. The company specializes in using advanced machine learning algorithms to streamline the drug development process, especially in preclinical stages. Cortex Discovery’s technology accelerates the identification and optimization of compounds, offering services such as virtual high-throughput screening, ADMET profiling (which predicts a drug's absorption, distribution, metabolism, excretion, and toxicity), and off-target screening. Their approach reduces the time and resources needed to develop new therapies by integrating AI with biological and chemical research.

Cortex Discovery is a pharmaceutical company focused on AI-driven drug discovery. The company specializes in using advanced machine learning algorithms to streamline the drug development process, especially in preclinical stages. Cortex Discovery’s technology accelerates the identification and optimization of compounds, offering services such as virtual high-throughput screening, ADMET profiling (which predicts a drug's absorption, distribution, metabolism, excretion, and toxicity), and off-target screening. Their approach reduces the time and resources needed to develop new therapies by integrating AI with biological and chemical research.

A notable focus of Cortex Discovery is longevity and age-related diseases, where they aim to develop compounds that address conditions such as cardiovascular diseases, cancer, and Alzheimer’s. Their platform also explores life-extending treatments by targeting mechanisms like oxidative stress and DNA repair. Through collaborations with academic labs, Cortex is working on therapies that could significantly extend human health spans